CD274 and non-small cell lung carcinoma: In this study patients receiving PD(L)-1 blockade for advanced NSCLC and showing a raised proportion of eosinophils at the time of first evaluation were more likely to show an objective response according to the RECIST criteria at the time of second evaluation, regardless of smoking history, PD-L1 status, and IRT.